AGC Biologics to expand cell line development with ATUM partnership
ATUM’s Leap-In platform enables AGC Biologics to offer various cell line development solutions for customers.
Drug Development
Citizen Health and UCB collaborate for epilepsy drug development
Solid Biosciences’ SGT-212 gains FDA rare paediatric disease status
Lotus submits NDA for VIZZ in South Korea to treat presbyopia
Eisai seeks PMDA approval for subcutaneous Leqembi in Japan
US FDA approves Lupin’s Armlupeg injection
IASO Bio gains Hong Kong approval for Fucaso application
MHRA approves Roche’s inavolisib for breast cancer
